Tessmer James F 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 16, 2021
Insider Transaction Report
Form 4
Tessmer James F
VP, Finance & Acctg
Transactions
- Sale
Common Stock
2021-03-15$6.92/sh−12,000$83,100→ 71,766 total - Exercise/Conversion
Common Stock
2021-03-15$3.31/sh+12,000$39,720→ 83,766 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-15−12,000→ 50,980 totalExercise: $3.31Exp: 2030-02-06→ Common Stock (12,000 underlying) - Sale
Common Stock
2021-03-15$6.90/sh−10,912$75,340→ 71,766 total
Footnotes (3)
- [F1]Executed in multiple trades at prices ranging from $6.90 to $6.92 per share. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Executed in multiple trades at prices ranging from $6.91 to $6.955. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.